28 June 2022 The South African Health Products Authority (SAHPRA) is pleased to
28 June 2022 Pretoria – The South African Health Products Regulatory Authority (
Embargo: Immediate release Pretoria, 24 June 2022 – The South African Health Pro
Embargo: Immediate release Pretoria, 23 June 2022 – SAHPRA has registered a new
23 June 2022 The South African Health Products Regulatory Authority (SAHPRA) has
23 June 2022 South Africa has recorded its first case of monkeypox today, 23 Jun
17 June 2022 CEO Perspectives and Horizons as Covid-19 takes a grip The SAHPRA C
07 June 2022 Embargo: Immediate release1. The COVID-19 vaccine LHC has been regi
30 May 2022 Embargo: Immediate release Pretoria, 30 May 2022 – The use of
27 May 2022 Embargo: Immediate release On 7 May 2022, the South African Health P
17 May 2022 At a four-day meeting at the Paul-Ehrlich-Institut, representatives
12 May 2022 Embargo: Immediate release In both the United States and South Afric
07 May 2022 Embargo: Immediate release Following the ruling by the Supreme Court
03 May 2022 Embargo: Immediate release Pretoria, 3 May 2022 – In October 2
20 April 2022 Embargo: Immediate release The South Africa Health Products Regula
08 April 2022 The South African Health Products Regulatory Authority (SAHPRA) of
08 April 2022 Embargo: Immediate release The South Africa Health Products Regula
31 March 2022 SAHPRA has assigned a non-compliant rating to the Emergent BioSolu
11 March 2022 Embargo: Immediate release The South Africa Health Products Regula
17 February 2022 Embargo: Immediate release Until recently, the treatment option
Embargo: Immediate release SAHPRA registered two COVID-19 vaccines: the COMIRNAT
7 February 2022 SAHPRA registered the SAHPRA registered the Comirnaty vaccine fr
14 January 2022 Embargo: Immediate release Joint Media Statement The South Afric
23 December 2021 Embargo: Immediate release The South African Health Products Re
8 December 2021 Embargo: Immediate release The South African Health Products Aut
7 December 2021 Please note that the SAHPRA office will be closed for the festiv
26 November 2021 Embargo: Immediate release SAHPRA has received an application f
22 November 2021 In June 2021, SAHPRA communicated that South Africa would not a
18 October 2021 SAHPRA has been engaged in a rolling review of the data for the
30 September 2021 Attention all stakeholders Post Importation Testing Exemptions
10 September 2021 The South African Health Products Authority (SAHPRA) has appro
3 September 2021 The South African Health Products Regulatory Authority (SAHPRA)
30 July 2021 The South African Health Products Regulatory Authority (SAHPRA) is
20 August 2021 The South African Health Products Regulatory Authority (SAHPRA) h
19 July 2021 As South Africa’s statutory health regulatory bodies, the South Afr
13 July 2021 Healthcare professionals and public health authorities have a centr
03 July 2021 The South African Health Products Regulatory Authority (SAHPRA) has
01 July 2021 The South African Health Products Regulatory Authority (SAHPRA) has
25 June 2021 The South African Health Products Regulatory Authority (SAHPRA) is
23 June 2021 SAHPRA has received documentation for the Sinopharm vaccine develop
21 June 2021 The South African Health Products Regulatory Authority (SAHPRA) is
13 June 2021 SAHPRA registered the Covid-19 Vaccine Janssen on 31 March 2021, wi
11 June 2021 Background World Health Organization (WHO) estimates from 2017 indi
7 June 2021 SAHPRA registered the Covid-19 Vaccine Janssen on 31 March 2021, wit
07 June 2021 To whom it may concern We draw your attention to the provisions o
24 May 2021 Boitumelo Semete-Makokotlela’s children have nicknamed her “meeting”
29 April 2021 Background Pregnant women are at higher risk of severe COVID-19 co
23 April 2021 Post Importation Testing Exemptions (PITE) granted due to COVID-19
22 April 2021 SAHPRA is pleased to announce the launch of the Med Safety App. Th
17 April 2021 SAHPRA has engaged with the Sisonke Phase 3B Implementation Study
13 April 2021 We have noted the decision taken by the Food and Drug Administrati
9 April 2021 On 6 April 2021 the Pretoria High Court issued a court order pertai
01 April 2021 The South African Health Products Authority (SAHPRA) registered th
29 March 2021 The SABC placed an erroneous report that “SAHPRA has agreed to all
25 March 2021 As the entire world ushered in 2020, no one had any idea how life,
19 March 2021 SAHPRA has implemented a new and improved online submission portal
19 March 2021 On 16 March 2021 SAHPRA registered Soolantra 10mg/g cream formulat
16 March 2021 SAHPRA has approved the Section 21 application for the Pfize
03 February 2021 There is an erroneous notion that SAHPRA “buckled under pressur
27 January 2021 In an effort to enable and support the country’s response in fig
06 January 2021 SAHPRA is pleased to announce the commencement of the build of a
22 December 2020 Post Importation Testing Exemptions (PITE) granted due to COVID
19 December 2020 Health Minister Dr Zweli Mkhize on Friday announced that a vari
10 December 2020 What is a Covid-19 Vaccine? A COVID‑19 vaccine is any of severa
04 December 2020 Coronavirus disease (COVID-19) is an infectious disease caused
19 November 2020 The Backlog Clearance Team has been made aware of a miscommunic
SAHPRA has implemented an application status checker. This new tool is listed un
Embargo: Immediate release SAHPRA has issued Section 21 authorisation for one se
In the interest of public health, SAHPRA has launched the COVI-Vig reporting sys
The Backlog Clearance Programme has received applications for Re-submission Wind
Business-As-Usual (BAU) process have been amended to be in line with new regulat
In its 25 November 2019 communication to stakeholders about cannabis and related
SAHPRA and B4SA under the Pharmaceutical and Vaccines working stream are collabo
In line with the recommendation of the South African National Institute for Comm
The document in the link below has been prepared to serve as a guideline to heal
The World Health Organisation (WHO) has declared COVID-19 to be a Public Health
The new coronavirus (COVID-19) will continue to have far-reaching consequences o
SAHPRA represented at the Commission on Narcotic Drugs (CND) 63rd session in Vie
Download PDF
SAHPRA- REVIEWING SCHEDULING STATUS OF CODEINE-CONTAINING MEDICINES The South Af
All walk-in clients who want to lodge applications or have queries mus
Download PDF
Download PDF
The South African Health Products Regulatory Authority (SAHPRA) is updating cert
10 May 2019 SAHPRA is the South African Health Products Regulatory Authority. It